Caffeine as a novel addition to the antivitiligo ammunition.
Feily
A
A
Saboktakin
M
M
D000279:Administration, Cutaneous; D002110:Caffeine / Q000008:administration & dosage / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014820:Vitiligo / Q000188:drug therapy*
D003879:Dermatologic Agents; D010726:Phosphodiesterase Inhibitors; D002110:Caffeine